- This topic has 2 replies, 3 voices, and was last updated 5 years ago by .
Viewing 3 posts - 1 through 3 (of 3 total)
Viewing 3 posts - 1 through 3 (of 3 total)
- You must be logged in to reply to this topic.
Where Independent Traders, Investors, and Dribblers Thrive
…
[article]544[/article]
Facebook Inc. $FB Analyst Response to Earnings
Barclays reiterated Overweight rating and raised target to $225 from $215
Credit Suisse reiterated Outperform rating and raised target price to $240 from $232.
KeyBanc Capital Markets reiterated Outperform rating and raised target to $225 from $200.
Pivotal Research maintained Sell rating but raised target to $152 from $147
CI still kicking himself in the ass for not picking up shares of FB even though he wanted to
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |